High levels of intravenous mephedrone (4-methylmethcathinone) self-administration in rats: Neural consequences and comparison with methamphetamine

Journal of Psychopharmacology

Volumn 27, Issue 9, 2013, Pages 823-836

  Motbey, Craig P ^a   Clemens, Kelly J ^b   Apetz, Nadine ^a   Winstock, Adam R ^c   Ramsey, John ^d   Li, Kong M ^a   Wyatt, Naomi ^e   Callaghan, Paul D ^e   Bowen, Michael T ^a   Cornish, Jennifer L ^b   McGregor, Iain S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b MACQUARIE UNIVERSITY   (Australia)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d ST GEORGE S HOSPITAL   (United Kingdom)

^e AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION   (Australia)

Author keywords

addiction; autoradiography; Mephedrone; neurotoxicity; self administration

Indexed keywords

4' METHYLMETHCATHINONE; 5 HYDROXYINDOLEACETIC ACID; CARRIER PROTEIN; DOPAMINE; DOPAMINE TRANSPORTER; METHAMPHETAMINE; SEROTONIN; SEROTONIN TRANSPORTER;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BODY WEIGHT; BRAIN TISSUE; CHEMICAL ANALYSIS; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DORSAL RAPHE NUCLEUS; DRUG DEPENDENCE; EX VIVO STUDY; HIPPOCAMPUS; LOCOMOTION; LONG TERM EXPOSURE; MALE; METABOLITE; NEUROTOXICITY; NONHUMAN; NUCLEUS ACCUMBENS; OLFACTORY BULB; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SEROTONIN BRAIN LEVEL; STRIATE CORTEX; SUBSTANTIA NIGRA; VENTRAL TEGMENTUM;

ADDICTION; AUTORADIOGRAPHY; MEPHEDRONE; NEUROTOXICITY; SELF-ADMINISTRATION;

ADMINISTRATION, INTRAVENOUS; ANIMALS; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HIPPOCAMPUS; MALE; METHAMPHETAMINE; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; RATS; RATS, SPRAGUE-DAWLEY; SELF ADMINISTRATION; SEROTONIN;

EID: 84883384731     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881113490325     Document Type: Article

References (63)

1. Angoa-Pérez M, Kane MJ, Francescutti DM, et al. Mephedrone, an abused psychoactive component of 'bath salts' and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatum. J Neurochem. 2012 ; 120: 1097-1107
2. Arlicot N, Katsifis A, Garreau L, et al. Evaluation of CLINDE as potent translocator protein (18 kDa) SPECT radiotracer reflecting the degree of neuroinflammation in a rat model of microglial activation. Eur J Nucl Med Mol Imaging. 2008 ; 35: 2203-2211
3. Arnold JM, Roberts D. A critique of fixed and progressive ratio schedules used to examine the neural substrates of drug reinforcement. Pharmacol Biochem Behav. 1997 ; 57: 441-447
4. Baumann MH, Ayestas MA, Partilla JS, et al. The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology. 2012 ; 37: 1192-203
5. Brunt TM, Poortman A, Niesink RJ, et al. Instability of the ecstasy market and a new kid on the block: Mephedrone. J Psychopharmacol. 2011 ; 25: 1543-7
6. Clemens KJ, Caillé S, Cador M. The effects of response operandum and prior food training on intravenous nicotine self-administration in rats. Psychopharmacology. 2010 ; 211: 43-54
7. Clemens KJ, Cornish JL, Hunt GE, et al. Intravenous methamphetamine self-administration in rats: Effects of intravenous or intraperitoneal MDMA co-administration. Pharmacol Biochem Behav. 2006 ; 85: 454-463
8. Cornish J, Hunt G, Robins L, et al. Regional c-Fos and FosB/ΔFosB expression associated with chronic methamphetamine self-administration and methamphetamine-seeking behavior in rats. Neuroscience. 2012 ; 206: 100-114
9. Cornish JL, Clemens KJ, Thompson MR, et al. High ambient temperature increases intravenous methamphetamine self-administration on fixed and progressive ratio schedules in rats. J Psychopharmacol. 2008 ; 22: 100-110
10. Cornish JL, Shahnawaz Z, Thompson MR, et al. Heat increases 3, 4-methylenedioxymethamphetamine self-administration and social effects in rats. Eur J Pharmacol. 2003 ; 482: 339-341
11. Dargan PI, Albert S, Wood DM. Mephedrone use and associated adverse effects in school and college/university students before the UK legislation change. Q J Med. 2010 ; 103: 875-879
12. Drugs-Forum (2011) Experiences - mephedrone (4-methylmethcathinone, 4-MMC) experiences. Available at: http://www.drugs-forum.com/forum/showthread. php?t=43273 (accessed 17 August 2012).
13. Erowid (2009) Dangerously addictive, but awesome. Available at: http://www.erowid.org/experiences/exp.php?ID=76345 (accessed 17 August 2012).
14. Erowid (2010) Serious addiction potential. Available at: http://www.erowid.org/experiences/exp.php?ID=85851 (accessed 17 August 2012).
15. Erowid (2011) Erowid experience vaults: 4-methylmethcathinone reports. Available at: http://www.erowid.org/experiences/subs/exp-4Methylmethcathinone. shtml (accessed 17 August 2012).
16. Escubedo E, Guitart L, Sureda FX, et al. Microgliosis and down-regulation of adenosine transporter induced by methamphetamine in rats. Brain Res. 1998 ; 814: 120-126
17. Fantegrossi WE, Ciullo JR, Wakabayashi KT, et al. A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4-methylenedioxymethamphetamine in the mouse. Neuroscience. 2008 ; 151: 533-543
18. Freeman TP, Morgan CJA, Vaughn-Jones J, et al. Cognitive and subjective effects of mephedrone and factors influencing use of a 'new legal high'. Addiction. 2012 ; 107: 792-800
19. Garrett G, Sweeney M. The serotonin syndrome as a result of mephedrone toxicity.. British Medical Journal Case Reports. 2010 ;:
20. Girden ER ANOVA: Repeated Measures. Thousand Oaks, California: Sage Publications ; 1991 :
21. Hadlock GC, Webb KM, McFadden LM, et al. 4-Methylmethcathinone (mephedrone): Neuropharmacological effects of a designer stimulant of abuse. J Pharmacol Exp Ther. 2011 ; 339: 530-536
22. Higgins GA, Fletcher PJ. Serotonin and drug reward: Focus on 5-HT2C receptors. Eur J Pharmacol. 2003 ; 480: 151-162
23. Huang P-K, Aarde SM, Angrish D, et al. Contrasting effects of d-methamphetamine, 3,4-methylenedioxymethamphetamine, 3,4- methylenedioxypyrovalerone, and 4-methylmethcathinone on wheel activity in rats. Drug Alcohol Depend. 2012 ; 126: 168-175
24. Kantak KM, Collins SL, Lipman EG, et al. Evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration model. Psychopharmacology. 2000 ; 148: 251-262
25. Karanges E, Li KM, Motbey C, et al. Differential behavioural and neurochemical outcomes from chronic paroxetine treatment in adolescent and adult rats: A model of adverse antidepressant effects in human adolescents?. Int J Neuropsychopharmacol. 2011 ; 14: 491-501
26. Kehr J, Ichinose F, Yoshitake S, et al. Mephedrone, compared to MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and serotonin levels in nucleus accumbens of awake rats. Br J Pharmacol. 2011 ; 164: 1949-1958
27. Krasnova IN, Justinova Z, Ladenheim B, et al. Methamphetamine self-administration is associated with persistent biochemical alterations in striatal and cortical dopaminergic terminals in the rat. PLoS ONE. 2010 ; 5: e8790
28. Letchworth SR, Nader MA, Smith HR, et al. Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys. J Neurosci. 2001 ; 21: 2799-2807
29. Lisek R, Xu W, Yuvasheva E, et al. Mephedrone ('bath salt') elicits conditioned place preference and dopamine-sensitive motor activation. Drug Alcohol Depend. 2012 ; 126: 257-262
30. López-Arnau R, Martínez-Clemente J, Pubill D, et al. Comparative neuropharmacology of three psychostimulant cathinone derivatives: Butylone, mephedrone and methylone. Br J Pharmacol. 2012 ; 167: 407-420
31. Malberg JE, Seiden LS. Small changes in ambient temperature cause large changes in 3, 4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat. J Neurosci. 1998 ; 18: 5086-5094
32. Martinez-Clemente J, Escubedo E, Pubill D, et al. Interaction of mephedrone with dopamine and serotonin targets in rats. Eur Neuropsychopharmacol. 2011 ; 22: 231-236
33. Maskell PD, De Paoli G, Seneviratne C, et al. Mephedrone (4-methylmethcathinone)-related deaths. J Anal Toxicol. 2011 ; 35: 188-191
34. Mattner F, Bandin DL, Staykova M, et al. Evaluation of [123 I]-CLINDE as a potent SPECT radiotracer to assess the degree of astroglia activation in cuprizone-induced neuroinflammation. Eur J Nucl Med Mol Imaging. 2011 ; 38: 1516-1528
35. McGregor IS, Clemens KJ, Van der Plasse G, et al. Increased anxiety 3 months after brief exposure to MDMA ('ecstasy') in rats: Association with altered 5-HT transporter and receptor density. Neuropsychopharmacology. 2003 ; 28: 1472-1484
36. Meng H, Cao J, Kang J, et al. Mephedrone, a new designer drug of abuse, produces acute hemodynamic effects in the rat. Toxicol Lett. 2011 ; 208: 62-68
37. Motbey CP, Hunt GE, Bowen MT, et al. Mephedrone (4-methylmethcathinone, 'meow'): Acute behavioural effects and distribution of Fos expression in adolescent rats. Addict Biol. 2011 ; 17: 409-422
38. Motbey CP, Karanges E, Li KM, et al. Mephedrone in adolescent rats: Residual memory impairment and acute but not lasting 5-HT depletion. PLoS ONE. 2012 ; 7 :
39. Munzar P, Laufert MD, Kutkat SW, et al. Effects of various serotonin agonists, antagonists, and uptake inhibitors on the discriminative stimulus effects of methamphetamine in rats. J Pharmacol Exp Ther. 1999 ; 291: 239-250
40. Newcombe R The use of mephedrone (M-cat, Meow) in Middlesbrough. Manchester: Lifeline Publications ; 2009 :
41. Norwood CS, Cornish JL, Mallet PE, et al. Pre-exposure to the cannabinoid receptor agonist CP 55,940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats. Eur J Pharmacol. 2003 ; 465: 105-114
42. Parrott AC. MDMA (3,4-Methylenedioxymethamphetamine) or ecstasy: The neuropsychobiological implications of taking it at dances and raves. Neuropsychobiology. 2004 ; 50: 329-335
43. Piazza PV, Deminière JM, Le Moal M, et al. Factors that predict individual vulnerability to amphetamine self-administration. Science. 1989 ; 245: 1511-1513
44. Pubill D, Canudas AM, Pallàs M, et al. Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity. Naunyn Schmiedebergs Arch Pharmacol. 2003 ; 367: 490-499
45. Ramoz L, Lodi S, Bhatt P, et al. Mephedrone ('bath salt') pharmacology: Insights from invertebrates. Neuroscience. 2012 ; 208: 79-84
46. Richardson NR, Roberts D. Progressive ratio schedules in drug self-administration studies in rats: A method to evaluate reinforcing efficacy. J Neurosci Methods. 1996 ; 66: 1-11
47. Robinson JE, Agoglia AE, Fish EW, et al. Mephedrone (4- methylmethcathinone) and intracranial self-stimulation in C57BL/6J mice: Comparison to cocaine. Behav Brain Res. 2012 ; 234: 76-81
48. Rothman RB, Baumann MH. Balance between dopamine and serotonin release modulates behavioral effects of amphetamine-type drugs. Ann N Y Acad Sci. 2006 ; 1074: 245-260
49. Rothman RB, Blough BE, Baumann MH. Dual dopamine-5-HT releasers: Potential treatment agents for cocaine addiction. Trends Pharmacol Sci. 2006 ; 27: 612-618
50. Rothman RB, Blough BE, Baumann MH Drug Addiction. Rapaka RS Sadée W, ed. Springer: New York ; 2008: 311-326.
51. Schenk S, Hely L, Lake B, et al. MDMA self-administration in rats: Acquisition, progressive ratio responding and serotonin transporter binding. Eur J Neurosci. 2007 ; 26: 3229-3236
52. Schwendt M, Rocha A, See RE, et al. Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion. J Pharmacol Exp Ther. 2009 ; 331: 555-562
53. Sim-Selley LJ, Selley DE, Vogt LJ, et al. Chronic heroin self-administration desensitizes μ opioid receptor-activated G-proteins in specific regions of rat brain. J Neurosci. 2000 ; 20: 4555-4562
54. Turchan J, Przewlocka B, Lason W, et al. Effects of repeated psychostimulant administration on the prodynorphin system activity and kappa opioid receptor density in the rat brain. Neuroscience. 1998 ; 85: 1051-1059
55. Van Hout MC, Brennan R. Plant food for thought: A qualitative study of mephedrone use in Ireland. Drugs (Abingdon Engl). 2010 ; 18: 371-381
56. Van Hout MC, Brennan R. Curiosity killed M-Cat: A post-legislative study on mephedrone use in Ireland. Drugs (Abingdon Engl). 2011 ; 19: 156-162
57. Wilson JM, Kish SJ. The vesicular monoamine transporter, in contrast to the dopamine transporter, is not altered by chronic cocaine self-administration in the rat. J Neurosci. 1996 ; 16: 3507-3510
58. Winstock A, Mitcheson L, Ramsey J, et al. Mephedrone: Use, subjective effects and health risks. Addiction. 2011a ; 106: 1991-1996
59. Winstock A, Mitcheson LR, Deluca P, et al. Mephedrone, new kid for the chop?. Addiction. 2011b ; 106: 154-161
60. Wise RA, Leone P, Rivest R, et al. Elevations of nucleus accumbens dopamine and DOPAC levels during intravenous heroin self-administration. Synapse. 1995 ; 21: 140-148
61. Wood DM, Davies S, Puchnarewicz M, et al. Recreational use of mephedrone (4-methylmethcathinone, 4-MMC) with associated sympathomimetic toxicity. J Med Toxicol. 2010 ; 6: 327-330
62. Yu YL, Fisher H, Sekowski A, et al. Amphetamine and fenfluramine suppress ethanol intake in ethanol-dependent rats. Alcohol. 1997 ; 14: 45-48
63. Zahm DS, Becker ML, Freiman AJ, et al. Fos after single and repeated self-administration of cocaine and saline in the rat: Emphasis on the basal forebrain and recalibration of expression. Neuropsychopharmacology. 2010 ; 35: 445-463